Literature DB >> 3542245

Fate and behavior of liposomes in vivo: a review of controlling factors.

J H Senior.   

Abstract

Of fundamental importance in the design of a therapeutic drug carrier system is a thorough understanding of the factors which control its fate in the living animal. The use of liposomes as a carrier system able to improve the therapeutic efficacy of a wide range of drugs, requires manipulation of its physical characteristics, thereby influencing in vivo behavior. This review brings together findings of recent studies which describe how liposomal stability and clearance in vivo are controlled by the architecture of the vesicles themselves which in turn, via interaction with humoral factors, controls the fate in terms of tissue distribution of the carrier and its contents. Based on these studies, a rationale for liposome design aimed at in vivo drug delivery is discussed.

Mesh:

Substances:

Year:  1987        PMID: 3542245

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  103 in total

1.  Well-defined, size-tunable, multifunctional micelles for efficient paclitaxel delivery for cancer treatment.

Authors:  Juntao Luo; Kai Xiao; Yuanpei Li; Joyce S Lee; Lifang Shi; Yih-Horng Tan; Li Xing; R Holland Cheng; Gang-Yu Liu; Kit S Lam
Journal:  Bioconjug Chem       Date:  2010-07-21       Impact factor: 4.774

2.  Solubilization of liposomes by weak electrolyte drugs. I. Propranolol.

Authors:  J A Rogers; G V Betageri; Y W Choi
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

3.  Therapeutic effect of liposomal superoxide dismutase in an animal model of retinopathy of prematurity.

Authors:  M R Niesman; K A Johnson; J S Penn
Journal:  Neurochem Res       Date:  1997-05       Impact factor: 3.996

4.  Development of novel nanocarrier-based near-infrared optical probes for in vivo tumor imaging.

Authors:  Yoichi Shimizu; Takashi Temma; Isao Hara; Ryo Yamahara; Ei-ichi Ozeki; Masahiro Ono; Hideo Saji
Journal:  J Fluoresc       Date:  2011-11-10       Impact factor: 2.217

5.  In vivo ESR studies on subcutaneously injected multilamellar liposomes in living mice.

Authors:  Klaus-Peter Moll; Reinhard Stösser; Werner Herrmann; Hans-hubert Borchert; Hideo Utsumi
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

Review 6.  Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective.

Authors:  R M Fielding
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

7.  Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.

Authors:  Yang Liu; Yunxia Hu; Leaf Huang
Journal:  Biomaterials       Date:  2014-01-02       Impact factor: 12.479

Review 8.  Nanomedicine--challenge and perspectives.

Authors:  Kristina Riehemann; Stefan W Schneider; Thomas A Luger; Biana Godin; Mauro Ferrari; Harald Fuchs
Journal:  Angew Chem Int Ed Engl       Date:  2009       Impact factor: 15.336

Review 9.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

Review 10.  A new look at lipid-membrane structure in relation to drug research.

Authors:  O G Mouritsen; K Jørgensen
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.